Though cancer death rates are decreased overall, there are still some
cancers that have poor survivability. One of those is glioblastoma, a type
of brain cancer that affects astrocyte cells in the brain.Researchers have
now created a gel that can be injected into the tumor cavity left following
surgery. The gel, which contains immunotherapies to help the immune system
to kill any remaining cancer cells, was tested in mice.
cancers that have poor survivability. One of those is glioblastoma, a type
of brain cancer that affects astrocyte cells in the brain.Researchers have
now created a gel that can be injected into the tumor cavity left following
surgery. The gel, which contains immunotherapies to help the immune system
to kill any remaining cancer cells, was tested in mice.
Dr. Aung Bajaj, a medical oncologist and hematologist said “glioblastoma
multiforme is considered the most aggressive type of brain tumor, and
patients who are diagnosed with glioblastoma multiforme typically live
around 1-2 years.”
“It is treated with surgical resection followed by a combination of
radiation and chemotherapy. If the cancer is maximally resected, the
prognosis tends to be better. However, maximum resection is not always
possible due to its infiltrative properties, where glioblastoma multiforme
coexists with normal brain tissue, and extensive surgery for complete
removal could compromise a patient’s neurologic function,” he noted.
